Director Dealings (6662D)
18 May 2012 - 9:01PM
UK Regulatory
TIDMAKT
RNS Number : 6662D
Ark Therapeutics Group PLC
18 May 2012
18 May 2012
Ark Therapeutics Group plc
Directors' Share Dealing
Ark Therapeutics Group plc (LSE: AKT) ("the "Company") has
received notification that on 17 May 2012 Peter Keen, Non-Executive
Director, purchased 750,000 ordinary shares of 1 pence each in the
Company through his Self Invested Pension Plan at a price of 2.85
pence per share.
As previously announced, Peter Keen retired as a Director with
effect from the conclusion of yesterday's Annual General Meeting of
the Company.
For further information please contact:
Ark Therapeutics Group plc
Dr Edward Bliss, Company Secretary +44 (0)20 7388 7722
This information is provided by RNS
The company news service from the London Stock Exchange
END
RDSKMGMKGRRGZZM
Premier Veterinary (LSE:PVG)
Historical Stock Chart
From Jun 2024 to Jul 2024
Premier Veterinary (LSE:PVG)
Historical Stock Chart
From Jul 2023 to Jul 2024
Real-Time news about Premier Veterinary Group Plc (London Stock Exchange): 0 recent articles
More ARK Therapeutics News Articles